Rep. Leitner urges prioritizing generics in Medicaid to cut drug costs; fiscal office warns rebate trade-offs Representative Leitner urged committee approval of HB 4839 to prioritize generics and biosimilars in Medicaid, citing sample savings; House Fiscal said Michigan pays roughly $4.1 billion in pharmacy costs with $2.4 billion in rebates and estimated gross savings of $5000 million but noted lost rebates could reduce net savings.

Michigan's Medicaid program could save up to $100 million by prioritizing generics and biosimilars, but the trade-offs in rebates raise tough questions for lawmakers.

Learn more here

#MI #CitizenPortal #GenericDrugPolicy #PharmaceuticalReform #HealthcareCosts